Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial (Q42606811)

3 November 2017

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial (English)

1 reference

3 November 2017

acute coronary syndrome

1 reference

2

1 reference

3 November 2017

3

Robert Califf

1 reference

3 November 2017

4

Maarten L Simoons

1 reference

3 November 2017

6

Lars Wallentin

1 reference

3 November 2017

1

Stefan James

1 reference

3 November 2017

5

Per Venge

1 reference

3 November 2017

7

Bertil Lindahl

1 reference

PubMed ID

12935823

3 November 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

American Journal of Medicine

3 November 2017

1 reference

3 November 2017

115

1 reference

3 November 2017

3

1 reference

3 November 2017

178-184

1 reference

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Angiographic findings in patients with refractory unstable angina according to troponin T status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

The Prognostic Value of Serum Troponin T in Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Cardiac biomarkers for rapid evaluation of chest pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900348-6

10.1016/S0002-9343(03)00348-6

7 January 2021

Identifiers

DOI

1 reference

3 November 2017

1 reference

PubMed ID

12935823